Dong M. Shin

57.7k total citations · 7 hit papers
361 papers, 26.7k citations indexed

About

Dong M. Shin is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Dong M. Shin has authored 361 papers receiving a total of 26.7k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Oncology, 131 papers in Molecular Biology and 101 papers in Otorhinolaryngology. Recurrent topics in Dong M. Shin's work include Head and Neck Cancer Studies (99 papers), Lung Cancer Treatments and Mutations (54 papers) and Cancer-related Molecular Pathways (39 papers). Dong M. Shin is often cited by papers focused on Head and Neck Cancer Studies (99 papers), Lung Cancer Treatments and Mutations (54 papers) and Cancer-related Molecular Pathways (39 papers). Dong M. Shin collaborates with scholars based in United States, China and South Korea. Dong M. Shin's co-authors include Zhuo Chen, Mark E. Davis, Fadlo R. Khuri, Shuming Nie, Waun Ki Hong, Robert I. Haddad, Xianghong Peng, A.R.M. Ruhul Amin, Merrill S. Kies and N. Azarnia and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Dong M. Shin

353 papers receiving 26.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

2006 3.7k citations Dong M. Shin et al. profile →
Nanoparticle therapeutics: an emerging treatment modality for cancer

2008 3.5k citations Zhuo Chen, Dong M. Shin et al. profile →
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags

2007 1.8k citations Ximei Qian, Dong M. Shin et al. profile →
Recent Advances in Head and Neck Cancer

2008 735 citations Dong M. Shin et al. profile →
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery

2006 580 citations Dong M. Shin et al. Molecular Cancer Therapeutics profile →
Application of Nanotechnology in Cancer Therapy and Imaging

2008 539 citations Zhuo Chen, Dong M. Shin et al. profile →
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer

2021 197 citations Mihir R. Patel, Dong M. Shin et al. profile →

Peers

Countries citing papers authored by Dong M. Shin

Since Specialization

Citations

This map shows the geographic impact of Dong M. Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong M. Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong M. Shin more than expected).

Fields of papers citing papers by Dong M. Shin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong M. Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong M. Shin. The network helps show where Dong M. Shin may publish in the future.

Co-authorship network of co-authors of Dong M. Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Dong M. Shin. A scholar is included among the top collaborators of Dong M. Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong M. Shin. Dong M. Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression 2024 ·Cells ·Hussein Sabit, Borros Arneth, Shaimaa Abdel-Ghany, (unknown), (unknown), Periasamy Selvaraj, Dong M. Shin, Ramireddy Bommireddy, Ahmed El-Hashash	16
2	Genomic and immune profiling of rare non-squamous sinonasal tumors. 2024 ·Journal of Clinical Oncology ·Conor Steuer, Daniel Lubin, Tolulope Adeyelu, James E. Bates, Dong M. Shin, Mihir R. Patel, Nicole C. Schmitt, William A. Stokes, Dara Bracken‐Clarke, Farah Abdulla, Charalampos S. Floudas, Matthew J. Oberley, Jennifer M. Johnson, Trisha M. Wise‐Draper, Marshall R. Posner, Nabil F. Saba	1
3	489 Statin drugs augment tumor response to anti-PD-1 immune check point blockade in head and neck cancer patients 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Conor Steuer, Dong M. Shin, Nabil F. Saba, Nicole C. Schmitt	1
4	Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood 2022 ·International Journal of Radiation OncologyBiologyPhysics ·David C. Qian, Bryan C. Ulrich, Gang Peng, Hongyu Zhao, Karen N. Conneely, Andrew H. Miller, Deborah Watkins Bruner, Ronald C. Eldridge, Evanthia C. Wommack, Kristin Higgins, Dong M. Shin, Nabil F. Saba, Alicia K. Smith, Barbara Burtness, Henry S. Park, (unknown), Jonathan J. Beitler, Canhua Xiao	1
5	Cytomorphologic and immunophenotypical analysis of SMARCA4 (BRG1)-deficient non-small cell lung carcinoma 2022 ·Journal of the American Society of Cytopathology ·(unknown), Xiaoqi Lin, Jason L. Hornick, Daniel Lubin, Qun Wang, Michelle D. Reid, Frank Schneider, Dehong Li, Dong M. Shin, Qiuying Shi	7
6	Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival 2021 ·Cancer Epidemiology Biomarkers & Prevention ·Ronald C. Eldridge, Karan Uppal, D. Neil Hayes, Matthew Ryan Smith, Xin Hu, Zhaohui Qin, Jonathan J. Beitler, Andrew H. Miller, Evanthia C. Wommack, Kristin Higgins, Dong M. Shin, Bryan C. Ulrich, David C. Qian, Nabil F. Saba, Deborah Watkins Bruner, Dean P. Jones, Canhua Xiao	5
7	Socioeconomic Factors Influence the Impact of Tumor HPV Status on Outcome of Patients With Oropharyngeal Squamous Cell Carcinoma 2021 ·JCO Oncology Practice ·Jennifer A. Marks, Jeffrey M. Switchenko, Conor Steuer, (unknown), Mihir R. Patel, Mark W. McDonald, Kristin Higgins, (unknown), Dong M. Shin, Theresa Gillespie, Nabil F. Saba	17
8	Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck 2020 ·Clinical Cancer Research ·Dong M. Shin, Sreenivas Nannapaneni, Mihir R. Patel, Qiuying Shi, Yuan Liu, Zhengjia Chen, Amy Y. Chen, Mark W. El‐Deiry, Jonathan J. Beitler, Conor Steuer, Steven M. Roser, Adam M. Klein, Taofeek K. Owonikoko, Suresh S. Ramalingam, Fadlo R. Khuri, Zhuo G. Chen, Nabil F. Saba	13
9	In Vitro and In Vivo Synergistic Antitumor Activity of the Combination of BKM120 and Erlotinib in Head and Neck Cancer: Mechanism of Apoptosis and Resistance 2017 ·Molecular Cancer Therapeutics ·(unknown), Abedul Haque, Dongsheng Wang, Mohammad Aminur Rahman, Chao Zhang, Zhengjia Chen, Zhuo Georgia Chen, Dong M. Shin, A.R.M. Ruhul Amin	18
10	Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin 2017 ·Clinical Cancer Research ·Xu Wang, Jonathan J. Beitler, Wen‐Chin Huang, Guo Chen, Guoqing Qian, Kelly R. Magliocca, Mihir R. Patel, Amy Y. Chen, Jun Zhang, Sreenivas Nannapaneni, Sungjin Kim, Zhengjia Chen, Xingming Deng, Nabil F. Saba, Zhuo Georgia Chen, Jack L. Arbiser, Dong M. Shin	23
11	Distinct pattern of TP53 mutations in human immunodeficiency virus–related head and neck squamous cell carcinoma 2017 ·Cancer ·Frederico O. Gleber‐Netto, Mei Zhao, Sanchit Trivedi, Jiping Wang, Samar A. Jasser, (unknown), Humam Kadara, Jiexin Zhang, Jing Wang, William N. William, J. Jack Lee, Minh Ly Nguyen, Sara I. Pai, Heather M. Walline, Dong M. Shin, Robert L. Ferris, Thomas E. Carey, Jeffrey N. Myers, Curtis R. Pickering	18
12	Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma 2014 ·Molecular Cancer Therapeutics ·Ning Jiang, Dongsheng Wang, Zhongliang Hu, Hyung Ju C. Shin, Guoqing Qian, Mohammad Aminur Rahman, Hongzheng Zhang, A.R.M. Ruhul Amin, Sreenivas Nannapaneni, Xiao‐Jing Wang, Zhengjia Chen, Gabriela Garcia, Gavin MacBeath, Dong M. Shin, Fadlo R. Khuri, Jun Ma, Zhuo G. Chen, Nabil F. Saba	50
13	Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303 2014 ·Clinical Cancer Research ·Ann Marie Egloff, Ju-Whei Lee, Corey J. Langer, Harry Quon, Alec Vaezi, Jennifer R. Grandis, Raja R. Seethala, Lin Wang, Dong M. Shin, Athanassios Argiris, Dong‐Hua Yang, Ranee Mehra, John A. Ridge, Urjeet A. Patel, Barbara Burtness, Arlene A. Forastiere	26
14	RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy 2013 ·Clinical Cancer Research ·Mohammad Aminur Rahman, A.R.M. Ruhul Amin, Dongsheng Wang, Lydia Koenig, Sreenivas Nannapaneni, Zhengjia Chen, Zhibo Wang, Gabriel Sica, Xingming Deng, Zhuo Chen, Dong M. Shin	99
15	Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies 2013 ·Clinical Cancer Research ·Dong M. Shin, Hongzheng Zhang, Nabil F. Saba, Amy Y. Chen, Sreenivas Nannapaneni, A.R.M. Ruhul Amin, Susan Müller, Melinda M. Lewis, Gabriel Sica, Scott A. Kono, Johann C. Brandes, William J. Grist, (unknown), Jonathan J. Beitler, Sufi M. Thomas, Zhengjia Chen, Hyung Ju C. Shin, Jennifer R. Grandis, Fadlo R. Khuri, Zhuo Georgia Chen	49
16	The Pivotal Role of Integrin β1 in Metastasis of Head and Neck Squamous Cell Carcinoma 2012 ·Clinical Cancer Research ·Dongsheng Wang, Susan J. Muller, A.R.M. Ruhul Amin, Donghai Huang, Ling Su, Zhongliang Hu, Mohammad Aminur Rahman, Sreenivas Nannapaneni, Lydia Koenig, Zhengjia Chen, Mourad Tighiouart, Dong M. Shin, Zhuo G. Chen	39
17	Detection of Circulating Tumor Cells in Human Peripheral Blood Using Surface-Enhanced Raman Scattering Nanoparticles 2011 ·Cancer Research ·Xu Wang, Ximei Qian, Jonathan J. Beitler, Zhuo Georgia Chen, Fadlo R. Khuri, Melinda M. Lewis, Hyung Ju C. Shin, Shaoping Nie, Dong M. Shin	292
18	Intratumoral Epidermal Growth Factor Receptor Antisense DNA Therapy in Head and Neck Cancer: First Human Application and Potential Antitumor Mechanisms 2009 ·Journal of Clinical Oncology ·Stephen Y. Lai, Priya Koppikar, Sufi M. Thomas, Erin E. Childs, Ann Marie Egloff, Raja R. Seethala, Barton F. Branstetter, William E. Gooding, Ashok Muthukrishnan, James M. Mountz, Vivian Wai Yan Lui, Dong M. Shin, Sanjiv S. Agarwala, (unknown), Larry A. Couture, Eugene N. Myers, Jonas T. Johnson, Gordon B. Mills, Athanassios Argiris, Jennifer R. Grandis	46
19	CXC Chemokine Receptor-4 Antagonist Blocks Both Growth of Primary Tumor and Metastasis of Head and Neck Cancer in Xenograft Mouse Models 2007 ·Cancer Research ·Younghyoun Yoon, Zhongxing Liang, Xin Zhang, (unknown), Aizhi Zhu, (unknown), Dong M. Shin, Mark M. Goodman, Zhuo Chen, Hyunsuk Shim	100
20	Correlation of Protease-Activated Receptor-1 With Differentiation Markers in Squamous Cell Carcinoma of the Head and Neck and Its Implication in Lymph Node Metastasis 2004 ·Clinical Cancer Research ·Xin Zhang, Jennifer L. Hunt, Doug Landsittel, Susan Müller, Karen Adler‐Storthz, Robert L. Ferris, Dong M. Shin, Zhuo Chen	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact